Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernhard Gerber

Showing results (101-110 of 138) with videos related to

Pageof 14
Sort By:
Journal of Thrombosis and Thrombolysis|August 18, 2020
Bleeding prevalence in COVID-19 patients receiving intensive antithrombotic prophylaxisChiara Kessler, Hans Stricker, Daniela Demundo, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 11, 2023
Prevalence of amyloid in ligamentum flavum of patients with lumbar spinal stenosisFrancesco Marchi, Chiara Kessler, Daniela Distefano, et al.
The Lancet. Digital Health|June 4, 2026
Development, validation, and user-centric evaluation of an interpretable machine learning decision support tool for the preoperative prediction of mild bleeding disorders (MBD-Check): a prospective diagnostic prediction studyHenning Nilius, Jonas Kaufmann, Marcel Adler, et al.
Research and Practice in Thrombosis and Haemostasis|September 10, 2024
Long-term course of ambulatory patients with COVID-19 initially treated with enoxaparin vs no anticoagulation: final analysis of the OVID (enoxaparin for outpatients with COVID-19) randomized trialRiccardo M Fumagalli, Davide Voci, Behnood Bikdeli, et al.
Eclinicalmedicine|December 2, 2022
A machine-learning model for reducing misdiagnosis in heparin-induced thrombocytopenia: A prospective, multicenter, observational studyHenning Nilius, Adam Cuker, Sigve Haug, et al.
Swiss Medical Weekly|April 5, 2024
Historic characteristics and mortality of patients in the Swiss Amyloidosis RegistrySofie Brouwers, Raphael Heimgartner, Natallia Laptseva, et al.
Blood Advances|September 9, 2021
Circulating tumor DNA for comprehensive noninvasive monitoring of lymphoma treated with ibrutinib plus nivolumabAlessio Bruscaggin, Lodovico Terzi di Bergamo, Valeria Spina, et al.
Haematologica|February 24, 2018
Circulating tumor DNA as a liquid biopsy in plasma cell dyscrasiasBernhard Gerber, Martina Manzoni, Valeria Spina, et al.
Hematological Oncology|June 3, 2022
Anatomical heterogeneity of residual disease in chronic lymphocytic leukemia treated with ibrutinibAdalgisa Condoluci, Lisa Milan, Gabriela Forestieri, et al.
Journal of Thrombosis and Haemostasis : JTH|June 8, 2021
The statistical risk of diagnosing coincidental acquired hemophilia A following anti-SARS-CoV-2 vaccinationMicol G Cittone, Raphael Battegay, Adalgisa Condoluci, et al.
Pageof 14

Showing results (101-110 of 138) with videos related to

Sort By:
Pageof 14
Journal of Thrombosis and Thrombolysis|August 18, 2020
Bleeding prevalence in COVID-19 patients receiving intensive antithrombotic prophylaxisChiara Kessler, Hans Stricker, Daniela Demundo, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 11, 2023
Prevalence of amyloid in ligamentum flavum of patients with lumbar spinal stenosisFrancesco Marchi, Chiara Kessler, Daniela Distefano, et al.
The Lancet. Digital Health|June 4, 2026
Development, validation, and user-centric evaluation of an interpretable machine learning decision support tool for the preoperative prediction of mild bleeding disorders (MBD-Check): a prospective diagnostic prediction studyHenning Nilius, Jonas Kaufmann, Marcel Adler, et al.
Research and Practice in Thrombosis and Haemostasis|September 10, 2024
Long-term course of ambulatory patients with COVID-19 initially treated with enoxaparin vs no anticoagulation: final analysis of the OVID (enoxaparin for outpatients with COVID-19) randomized trialRiccardo M Fumagalli, Davide Voci, Behnood Bikdeli, et al.
Eclinicalmedicine|December 2, 2022
A machine-learning model for reducing misdiagnosis in heparin-induced thrombocytopenia: A prospective, multicenter, observational studyHenning Nilius, Adam Cuker, Sigve Haug, et al.
Swiss Medical Weekly|April 5, 2024
Historic characteristics and mortality of patients in the Swiss Amyloidosis RegistrySofie Brouwers, Raphael Heimgartner, Natallia Laptseva, et al.
Blood Advances|September 9, 2021
Circulating tumor DNA for comprehensive noninvasive monitoring of lymphoma treated with ibrutinib plus nivolumabAlessio Bruscaggin, Lodovico Terzi di Bergamo, Valeria Spina, et al.
Haematologica|February 24, 2018
Circulating tumor DNA as a liquid biopsy in plasma cell dyscrasiasBernhard Gerber, Martina Manzoni, Valeria Spina, et al.
Hematological Oncology|June 3, 2022
Anatomical heterogeneity of residual disease in chronic lymphocytic leukemia treated with ibrutinibAdalgisa Condoluci, Lisa Milan, Gabriela Forestieri, et al.
Journal of Thrombosis and Haemostasis : JTH|June 8, 2021
The statistical risk of diagnosing coincidental acquired hemophilia A following anti-SARS-CoV-2 vaccinationMicol G Cittone, Raphael Battegay, Adalgisa Condoluci, et al.
Pageof 14